Medication vaporizer inhaler

Abstract

The present invention discloses a drug vaporizing inhaler. In this invention, when a patient with asthma or coronavirus infection inhales a granular drug, the drug is contained in the vaporized vapor, thereby enabling the drug to reach the lungs of the patient with asthma or coronavirus infection without loss, preventing a portion of the drug from remaining in the inhalation container, preventing excessive inhalation of the drug, and improving the drug inhalation efficiency of the patient with asthma or coronavirus infection.

Description

Technical Field

[0001] The present invention relates to a drug vaporizing inhaler, and more particularly to a drug vaporizing inhaler that mixes the inhaled granular drug with vaporized steam when a patient with an infection such as asthma or coronavirus inhales the granular drug, so that the drug can fully reach the lungs. Technical Background

[0002] Generally speaking, with the development of civilization, modern people suffer from diseases called civilization diseases such as bronchial asthma and atopic dermatitis due to various public hazards and pollution.

[0003] In order to solve the above problems and achieve the effects of improving physical and mental stability and immunity, promoting health, and replacing negative culture in our society such as smoking, a lot of research has been done on portable inhalers so that aromas or medicines can be used anytime and anywhere, and the benefits can be obtained regardless of time and place.

[0004] That is, the development of drugs for the treatment of asthmatic patients or patients infected with the coronavirus that has recently emerged and caused a lot of damage worldwide, in addition to the administration of bronchial active compounds in the form of metered aerosols and inhalable solvents, the use of inhalation powders containing the active substances is particularly important.

[0005] Especially for active substances with high efficacy, only a small amount of active substance is required per administration to achieve a therapeutic effect. In this case, the inhalation powder is prepared by diluting the active substance with a suitable excipient.

[0006] Due to the large amount of excipients used, the properties of inhalation powders are greatly affected by the choice of excipients. When selecting excipients, particle size is particularly important. Generally speaking, the finer the excipient, the worse the flowability.

[0007] However, when packaging and dividing in individual doses, for example when preparing capsules (inhalettes) for powder inhalation, or when the patient meters individual doses before using a multidose powder inhaler, good flowability is a prerequisite for very precise metering.

[0008] Also, when used in an inhaler, the particle size of the excipient is very important for the discharge characteristics of the capsule. Also, it is well known that the particle size of the excipient has an important influence on the proportion of active substance in the inhalation powder delivered by inhalation. The inhalation proportion of active substance refers to the particles of the inhalation powder that will move deep into the lung branches when inhaled by breathing, and the required particle size is between 1-10 μm, preferably less than 6 μm.

[0009] However, in the existing powder inhaler that sprays micropowder as fine particles, when the granular drug is inhaled, the inhaled granular drug is often not fully inhaled into the lungs and a part of the drug remains in the inhaler. Therefore, considering the amount of loss, there is a problem that patients with asthma or coronavirus infections inhale excessive drugs.

[0010] Summary of the invention

[0011] Technical problem to be solved by the invention

[0012] The problem to be solved by the present invention is to provide a drug vaporizing inhaler, which contains the drug in the vaporized steam when the patient with asthma or the coronavirus infection that has recently occurred and is spreading inhales the granular drug, thereby enabling the drug to reach the lungs of the patient with asthma or the coronavirus infection without loss, preventing a part of the drug from remaining in the inhalation container, and preventing excessive inhalation of the drug.

[0013] Technical solutions to solve problems

[0014] As a solution to the problem of the present invention, a drug vaporizing inhaler according to one embodiment includes: a vaporizing container having a first storage space for accommodating a vaporization-promoting composition and a first guide flow path for discharging vapor; an induction portion arranged to be inserted from the lower portion of the vaporizing container into the first storage space, and inducing the vaporization-promoting composition accommodated in the first storage space to be discharged through a capillary phenomenon; a particulate vaporizing portion that generates heat when powered on, so as to vaporize the vaporization-promoting composition induced by the induction portion; and a main body portion that is detachably coupled to the upper portion of the vaporizing container, and having a capsule accommodating portion formed on the upper surface for accommodating a capsule, wherein the capsule is sealed and stored with powdered drugs for asthma or coronavirus-infected patients, The main body has a second guide flow path for discharging steam inside, the second guide flow path runs through the upper and lower areas and is connected to the first guide flow path, and sprays the vaporized steam flowing in from the bottom surface and induced by the vaporization part toward the capsule located in the capsule receiving part; and a cover part, which can be rotatably coupled to the upper surface of the main body to form a mixing space, has an inhalation contact tube for asthma or coronavirus-infected patients connected to the mixing space and a blade for cutting the capsule received in the capsule fixing part, and contains the steam vaporized through the inhalation contact tube or the powder medicine discharged from the capsule in the vaporized steam guided by the second guide flow path to be inhaled into the lungs of asthma or coronavirus-infected patients.

[0015] According to one aspect of the present invention, the capsule housing portion forms a space for housing the capsule by means of a pair of first wall components and a pair of second wall components facing each other, the first wall component supports the left and right side surfaces of the capsule, the second wall component is spaced apart in a direction different from the first wall component and supports both side ends of the capsule, and a blade moving flow path through which the blade passes is formed between the first wall component and the second wall component, so that when the cover portion rotates, the upper side of the capsule is cut by the blade.

[0016] According to another aspect of the present invention, the main body is combined with the upper part of the vaporizing container, a guide groove for guiding the rotation of the cover is formed on the upper surface edge side of the main body, and protrusion insertion grooves are formed at both ends of the guide groove.

[0017] According to another aspect of the present invention, a pair of blades are formed to protrude from the inner side end of the cover, and a locking protrusion is formed on the inner surface edge side of the cover to be placed in the protrusion insertion groove of the body and rotate along the guide groove.

[0018] According to another aspect of the present invention, a first indicator portion and a second indicator portion may be respectively formed on the outer peripheral surface of the main body portion having the protrusion insertion groove and the outer peripheral surface of the cover portion having the locking protrusion, for guiding a discharge position where only the steam vaporized through the inhalation contact tube is discharged, or a mixed steam discharge position where the powdered medicine discharged from the capsule can be contained in the vaporized steam and discharged.

[0019] According to another aspect of the present invention, the second guide flow path is formed in a twisted tubular shape penetrating vertically, so that when the vaporized steam is sprayed toward the capsule located between the body and the cover, a vortex can be formed in the mixing space provided between the cover and the body.

[0020] According to another aspect of the present invention, preferably, the second guide flow path forms an "L"-shaped channel connected from the bottom surface of the main body to the inner wall surface of the capsule housing portion, and the inner outlet of the channel is adjacent to the blade moving flow path separated by the space between the plate-shaped first wall component and the arc-shaped second wall component arranged in the capsule housing portion.

[0021] According to another aspect of the present invention, the second guide flow path has a vertical flow path and a horizontal flow path, which as a whole form a connecting channel with an "L"-shaped end face. The vertical flow path is formed along the vertical direction from the bottom surface of the main body, and the horizontal flow path is laterally connected to the vertical flow path and the outlet is open to the inner wall surface of the capsule receiving portion.

[0022] According to another aspect of the present invention, preferably, the horizontal flow path open to the inner wall surface of the capsule housing portion maintains an inclination of 15 to 45 degrees from the center of the main body to one side, so that the vaporized steam passing through the first guide flow path and ejected through the second guide flow path for exhausting steam is directed toward the cut surface of the capsule cut on the upper side with the help of a blade for cutting a portion of the capsule surface, and at the same time can form a vortex in the mixing space.

[0023] Furthermore, the vaporization container further comprises a liquid inlet valve for adding the vaporization promoting composition.

[0024] Furthermore, the first guide flow path is partitioned and disposed at the center of the vaporizing container or is formed along the inner circumferential surface of the vaporizing container.

[0025] Furthermore, the induction portion is fixed to a fixing plate formed with an air inflow hole, so as to divide the space inside the vaporization container or the particulate vaporization portion into an inner space and an outer space.

[0026] Furthermore, the induction part is made of a material selected from the group consisting of multi-layer nickel foam mesh, stainless steel fiber felt, polymer foam, metal porous body, fiber, or a combination thereof.

[0027] Furthermore, the particulate vaporization section includes: an atomization container, which is combined with the lower part of the vaporization container and is used to accommodate the fixing plate to which the induction section is fixed; an electrode section for power supply, which is threadedly coupled to the atomization container; and a heating element, which is formed on the outer surface of the induction section accommodated in the atomization container and generates heat according to the power supplied from the electrode section, so that the vaporization induced by the induction section promotes the vaporization of the composition.

[0028] Furthermore, the electrode portion includes: an electrode body having an inlet connected to the first guide flow path and a mating threaded portion fixed in electrical contact with the inner bottom surface of the atomizing container, wherein the atomizing container has a hollow structure with both ends open; a negative (-) electrode formed on one side of the electrode body and in electrical contact with the heating element; and a positive (+) electrode formed on one side of the electrode body and in electrical contact with the heating element.

[0029] Furthermore, the heating element is applicable to one selected from the following: a heating wire in the form of a filament, connected to the electrode and wound around the induction part, having a coil structure made of a nickel alloy or a composite material of rare earth elements; a high-frequency or ultra-high-frequency generating device, connected to the electrode, the induction part is formed as a flat plate structure closely attached to the high-frequency or ultra-high-frequency generating device; including a Peltier element electrically connected in parallel with the electrode, the heat absorption plate of the Peltier element is in physical contact with the heating element; a combination of a heating wire in the form of a filament and a high-frequency or ultra-high-frequency generating device, wherein the heating wire is connected to the electrode and wound around the induction part, having a coil structure made of a nickel alloy or a composite material of rare earth elements; including a Peltier element electrically connected in parallel with the electrode, the heat absorption plate of the Peltier element is in physical contact with the heating element.

[0030] Furthermore, the vaporization promoting composition may be one of general nutrients, minerals, vitamins, amino acids, and physiologically active agents.

[0031] Effects of the Invention

[0032] Therefore, the present invention can be expected to have the following effects: when a patient infected with asthma or coronavirus inhales a granular drug, the drug is contained in the vaporized steam, thereby enabling the drug to reach the lungs of the patient infected with asthma or coronavirus without loss, preventing a portion of the drug from remaining in the inhalation container, preventing excessive inhalation of the drug, and at the same time improving the drug inhalation efficiency of the patient infected with asthma or coronavirus.

[0033] The effects of the present invention are not limited to the above-mentioned effects, and other effects not mentioned will be clearly understood by those skilled in the art from the description of the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 The figure is an exploded perspective view showing the structure of a medicine vaporizing inhaler according to an embodiment of the present invention.

[0035] Figure 2 The combined cross-sectional view shows the structure of a medicine vaporizing inhaler according to an embodiment of the present invention.

[0036] Figure 3 It is an enlarged stereoscopic view showing the structure of the main body of one embodiment of the present invention.

[0037] Figure 4 To show an embodiment of the present invention Figure 3 Schematic diagram of the floor plan.

[0038] Figure 5 It is an enlarged three-dimensional view showing the cover structure of one embodiment of the present invention.

[0039] Figure 6 In one embodiment of the present invention Figure 5Schematic diagram of the floor plan.

[0040] Figure 7 It is an enlarged perspective view showing the structure of the main body of the second embodiment of the present invention.

[0041] Figure 8 (a) and (b) show the second embodiment of the present invention. Figure 7 A top view and a brief bottom view. DETAILED DESCRIPTION

[0042] Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings.

[0043] Figure 1 This is an exploded perspective view showing the structure of a drug vaporizing inhaler according to an embodiment of the present invention. Figure 2 A combined cross-sectional view showing the structure of a drug vaporizing inhaler according to an embodiment of the present invention is shown in FIG. Figure 3 It is an enlarged stereoscopic view showing the structure of the main body of an embodiment of the invention.

[0044] Figure 4 To show an embodiment of the present invention Figure 3 A plan view of Figure 5 This is an enlarged perspective view showing the cover structure of an embodiment of the present invention. Figure 6 In one embodiment of the present invention Figure 5 Schematic diagram of the floor plan.

[0045] Reference Figures 1 to 6 The medicine vaporizing inhaler according to an embodiment of the present invention includes a vaporizing container 10 , an inducing portion 20 , a microparticle vaporizing portion 30 , a body portion 40 , and a cover portion 50 .

[0046] The vaporization container 10 may include a first storage space 11 for accommodating a vaporization promoting composition and a first guide flow path 12 for discharging vapor. When the vaporization promoting composition is vaporized by the particulate vaporization portion 30 , the first guide flow path 12 discharges the vaporized vapor to the main body 40 .

[0047] The vaporization container 10 is provided with a liquid inlet valve 13 for adding the vaporization promoting composition, and the first guide flow path 12 is separately disposed in the center of the vaporization container 10 or formed along the inner circumference of the vaporization container 10 .

[0048] That is, the vaporizing container 10 is a hollow structure, the center of which is provided with the first guide flow path 12 in a buried state, and the periphery of the first guide flow path 12 may have an integrated communication structure.

[0049] The vaporization promoting composition is an element harmless to the human body, and can be one of general nutrients, minerals, vitamins, amino acids, and physiologically active agents.

[0050] The general nutrients can be selected from one of water, protein, lipid, carbohydrate, insoluble dietary fiber, soluble dietary fiber, total dietary fiber and sugar; the minerals can be selected from one of calcium, phosphorus, iron, sodium, magnesium, manganese, zinc, cobalt, copper, molybdenum, selenium, fluorine, iodine, ash, calcium, phosphorus, iron, sodium, zinc or a combination of two; the vitamins can be selected from one of vitamin A, retinol (RE), β-carotene, thiamine, riboflavin, niacin, vitamin C, vitamin B6, pantothenic acid, vitamin B12, folic acid, vitamin D, vitamin E, vitamin K, vitamins, thiamine or a combination of two; the amino acids can be selected from isoleucine, leucine, lysine, methylthio The physiologically active agent can be selected from one or a combination of two of amino acid, cysteine, phenylalanine, tyrosine, threonine, tryptophan, valine, histidine, arginine, aspartic acid, glutamic acid, glycine, proline, and serine; the physiologically active agent can be selected from daidzein, genistein, glycitein, anthocyanidin, delphinidin, malvidin, pelargonidin, peonyrin, morning glory pigment, epicatechin, epicatechin-3-gallate, epigallocatechin, epigallocatechin gallate (Epigallocatechin-3-gallate), epigallocatechin-3-gallate, ... 3-gallate), catechin, gallocatechin, eriodictyol, hesperidin, naringenin, epidermin, luteolin, isorhamnetin, kaempferol, myricetin, quercetin, monomeric proanthocyanidins, dimeric proanthocyanidins, trimeric proanthocyanidins, 4-6-mer proanthocyanidins, 7-10-mer proanthocyanidins, polymeric proanthocyanidins, choline, betaine, procholine, glycerophosphocholine, phosphorylcholine, phosphatidylcholine, and a combination of one or two of sphingomyelin.

[0051] In addition, the vaporization promoting composition may further include one or a combination of two or more selected from the following ingredients: amino acids, Ginkgo Biloba, Coenzyme Q10 (Co-Q10), Phosphatidyl Serine (PS), Alpha Lipoic Acid (Alpha Lipoic A nutrient component in green tea, polygonatum root, schisandra tea, ophiopogon tea, corn silk tea, plum tea, tangerine peel tea, tangerine peel tea, chrysanthemum tea, acanthopanax bark, papaya, kudzu vine, wolfberry, cornus officinalis, persimmon leaf, eucommia bark, oolong tea, and wintergreen seed tea; a fruit component in orange, lemon, and grapefruit; a vegetable component in broccoli extract, cabbage extract, onion, garlic, ginger, lettuce extract, kale extract, platycodon extract, and tomato extract; a traditional Chinese medicine component in ginkgo leaf, raspberry, wolfberry, schisandra, cnidium monnieri, dodder seed, cornus officinalis, and cassia seed; a functional component in royal jelly, plum, Hovenia dulcis, and xylitol.

[0052] The induction portion 20 is arranged in a state of being closely attached to or inserted into the lower part of the vaporization container 10, and induces the vaporization promoting composition contained in the first storage space 11 to be discharged through a capillary phenomenon. It can be fixed to a fixing plate 21 having an air inflow hole 21a connected to the first guide flow path 12, so as to divide the space inside the vaporization container 10 or the particulate vaporization portion 30 into an internal space and an external space.

[0053] At this time, the induction part 20 can be made of a material selected from the group consisting of multi-layer nickel foam mesh, stainless steel fiber felt, polymer foam, metal porous body, fiber, or a combination thereof.

[0054] The inducing portion 20 is in direct contact with the vaporization promoting composition in the first storage space 11 to shorten the moving path of the vaporization promoting composition. This is to prevent the viscosity from causing a decrease in fluid movement when the vaporization promoting composition has high viscosity.

[0055] During the installation process, there may be a gap between the induction portion 20 and the lower portion of the vaporization container 10. Since there is a risk that the vaporization promoting composition stored in the first storage space 11 may leak due to this gap, the vaporization promoting composition is prevented from leaking by accommodating a fiber material inside the first storage space 11.

[0056] On the other hand, in the embodiment of the present invention, the inducing portion 20 has been described as being arranged in a state where the end portion is inserted into the lower portion of the vaporization container 10. However, considering the risk of leakage of the vaporization promoting composition, although not shown in the figure, in another embodiment of the present invention, the end portion of the inducing portion 20 may also be closely attached to or in contact with the lower portion of the vaporization container 10. In this case, the lower portion of the vaporization container 10 is not a structure for setting the inducing portion 20 in an inserted state, and therefore a connecting groove may not be formed.

[0057] As a result, according to another embodiment of the present invention, as a structure for making the inducing part 20 close to the connecting groove, the inducing part 20 has a diameter designed to be larger than the connecting groove, and then the end portion of the inducing part 20 is bonded to the outer periphery of the connecting groove using silicon, or the inducing part 20 has a diameter designed to be larger than the connecting groove, and then pressure is applied to the connecting groove to set the inducing part 20, so that the vaporization promoting composition leaked through the connecting groove can be absorbed by the inducing part 20.

[0058] The particulate vaporization unit 30 generates heat when powered on, vaporizing the vaporization-promoting composition induced by the induction unit 20 , and includes an atomization container 31 , an electrode unit 32 , a heating element 33 , and a housing 34 .

[0059] The atomizing container 31 is combined with one end of the vaporizing container 10 and the other end is combined with the housing 34 , and is used to accommodate the fixing plate 21 to which the guiding part 20 is fixed.

[0060] The electrode portion 32 is combined in the atomizing container 31 and is used to supply power to the heating element 33 .

[0061] That is, the electrode portion 32 includes an electrode body 321, the electrode body 321 has an inlet 321a connected to the first guide flow path 12 and a mating threaded portion 321b fixed in electrical contact with the inner bottom surface of the atomization container 31 with a hollow structure opened on both side ends, and on one side of the electrode body 321 there are a negative (-) electrode 322 and a positive (+) electrode 323 in electrical contact with the heating element 33.

[0062] The heating element 33 is formed on the outer surface of the induction unit 20 accommodated in the atomization container 31 , and generates heat according to the power supplied from the electrode unit 32 , so that the vaporization promotion composition induced by the induction unit 20 is vaporized.

[0063] At this time, the heating element 33 may be a heating wire in the form of a filament, which is connected to the electrodes 322 and 323 and wound around the induction portion 20 and has a coil structure made of a nickel alloy or a composite material of rare earth elements.

[0064] On the other hand, the heating element 33 may be a high frequency or ultra high frequency generating device connected to the electrodes 322 and 323. In this case, the inducing portion 20 may also be formed into a flat plate structure closely attached to the high frequency or ultra high frequency generating device.

[0065] Furthermore, the heating element 33 may include a Peltier element electrically connected to the electrodes 322 and 323 , and a heat absorbing plate of the Peltier element is in physical contact with the heating element 33 .

[0066] Furthermore, the heating element 33 may be a combination of a heating wire in the form of a filament and a high-frequency or ultra-high-frequency generating device, wherein the heating wire is connected to the electrodes 322 , 323 and wound around the induction portion 20 , and has a coil structure made of a nickel alloy or a composite material of rare earth elements, or may include a Peltier element electrically connected to the electrodes 322 , 323 , and a heat absorbing plate of the Peltier element is in physical contact with the heating element 33 .

[0067] The main body 40 is detachably coupled to the upper portion of the vaporizer container 10, and a capsule receiving portion 42 for receiving a capsule 41 is formed on the upper surface thereof. The capsule is sealed to store powder medicine for patients infected with asthma or coronavirus. Figures 1 to 4 A first embodiment in which the capsule receiving portion 42 protrudes is shown. Figure 7 and Figure 8 A second embodiment in which the capsule receiving portion 42 is recessed is shown, and a second guide flow path 43 for discharging steam is formed inside the main body 40, and the second guide flow path 43 passes through the upper and lower areas and is connected to the first guide flow path 12. The second guide flow path 43 is arranged toward a capsule 41 that seals and stores powdered medicines for patients infected with asthma or coronavirus, etc., and is located on the outside of the capsule receiving portion 42.

[0068] Meanwhile, a guide groove 44 for guiding the rotation of the cover part 50 may be formed at an edge side of an upper surface of the body part 40 , and protrusion insertion grooves 45 are formed at both ends of the guide groove 44 .

[0069] The first embodiment of the capsule receiving portion 42 is shown in Figures 1 to 6 The capsule accommodating portion 42 protruding from the upper surface of the main body 40 forms a space for accommodating the capsule 41 by a pair of plate-like first wall members 42a, 42a' and a pair of opposing second wall members 42b, 42b'. The first wall members 42a, 42a' support the left and right side surfaces of the capsule 41, and the second wall members 42b, 42b' are spaced apart in a direction different from the first wall members 42a, 42a' and support the two side ends of the capsule 41 in an arc shape.

[0070] A blade moving flow path 42c formed in a spaced manner is provided between the plate-like first wall parts 42a, 42a' and the arc-shaped second wall parts 42b, 42b' to ensure space for the blade 53 to pass through, so that when the cover part 50 rotates, the upper side of the capsule 41 is cut.

[0071] The second embodiment of the capsule receiving portion 42 is shown in Figure 7 and Figure 8 . Figure 7 The main body structure of another embodiment of the present invention is enlarged. Figure 8 (a) and (b) are respectively showing another embodiment of the present invention Figure 7 A top view and a bottom view of the main body of the device.

[0072] The capsule housing portion 42 according to the second embodiment of the present invention is shown as the capsule housing portion 42 which is recessed from the upper surface of the main body portion 40, and has a pair of plate-like first wall components 42a and a pair of arc-shaped second wall components 42b facing each other, the first wall component 42a supporting the left and right side surfaces of the capsule 41, the second wall component 42b being spaced apart and supporting the two side ends of the capsule 41 in a direction different from that of the first wall component 42a, and a blade moving flow path 42c being ensured between the plate-like first wall component 42a and the arc-shaped second wall component 42b, so that when the cover portion 50 rotates, one side of the upper side of the capsule 41 is cut.

[0073] Furthermore, the cover 50 is rotatably coupled to the upper surface of the main body 40 , and a mixing space 51 is formed at an inner lower portion thereof to face the capsule housing portion 42 provided on the upper surface of the main body 40 .

[0074] An open structure penetrating from top to bottom is formed in the center of the mixing space 51, and an inhalation contact tube 52 for asthma or coronavirus-infected patients connected to the upper side is formed. A blade 53 is protruding downward from the inner bottom surface of the cover portion 50, and is used to cut a portion of the surface of the capsule 41 placed in the capsule receiving portion 42.

[0075] When the cover portion 50 rotates, the blade 53 for cutting a portion of the capsule surface passes through the blade moving flow path 42c, which is located in the space between the plate-shaped first wall component 42a and the arc-shaped second wall component 42b in the capsule receiving portion 42 arranged on the upper surface of the main body portion 40, and cuts the upper side surface of the capsule 41 placed in the capsule receiving portion 42, so that the powdered medicine can be discharged from the capsule 41.

[0076] A second guide flow path 43 is formed outside the capsule housing portion 42 disposed on the upper surface of the main body 40 to eject vaporized steam toward the capsule 41 housed in a state fixed by the plate-shaped first wall member 42a and the arc-shaped second wall member 42b.

[0077] At this time, the second guide flow path 43 is arranged in a manner of penetrating the upper and lower areas, and the vaporized steam induced by the first guide flow path 12 is sprayed toward the capsule 41. The blade 53 that cuts a portion of the capsule surface is used to include the powdered medicine discharged from the capsule 41 cut on the upper side in the vaporized steam, so that the user can inhale it through the inhalation contact tube 52.

[0078] Preferably, when the vaporized steam is sprayed toward the capsule 41 between the body 40 and the cover 50, the second guide flow path 43 can form a vortex in the mixing space 51 between the cover 50 and the body 40, so that as shown in the first embodiment Figures 1 to 6 As shown, in the case of forming the vertical through type, it is formed in a twisted tubular shape.

[0079] However, if Figure 7 and Figure 8 As shown, the second guide flow path 43 of the second embodiment is formed in the shape of a recessed capsule receiving portion 42 and has a vertical flow path 43a and a horizontal flow path 43b, forming a connecting channel with an "L"-shaped end face as a whole. The vertical flow path 43a is formed along the vertical direction from the bottom surface of the main body 40, and the horizontal flow path 43b is laterally connected to the vertical flow path 43a and the outlet is open to the inner wall surface of the capsule receiving portion 42.

[0080] At this time, the horizontal flow path 43b opened to the inner wall surface of the capsule receiving portion 42 maintains an inclination of 15 to 45 degrees from the center of the main body 40 to one side, so that the vaporized steam passing through the first guide flow path 12 and ejected through the second guide flow path 43 for exhausting steam is directed toward the cut surface of the capsule 41 cut on the upper side by means of the blade 53 for cutting a part of the capsule surface. At the same time, the powder medicine separated on the cut surface of the capsule 41 is rotated and mixed by means of the injection pressure of the vaporized steam ejected from the upper and lower directions, thereby forming a vortex in the mixing space 51 arranged between the cover portion 50 and the main body 40.

[0081] In other words, the outlet of the second guide flow path 43 is directed toward the blade moving flow path 42 c provided in the partition space between the first wall member 42 a and the second wall member 42 b in the capsule housing portion 42 .

[0082] Thus, the vaporized steam injected into the capsule 41 can directly contact the powder medicine discharged from the cut upper side of the capsule 41 by means of the blade 53 for cutting a portion of the capsule surface, thereby maximizing the powder medicine mixing effect.

[0083] A locking protrusion 54 is formed on the edge side of the inner surface of the cover portion 50, which is placed in the protrusion insertion groove 45 and rotates along the guide groove 44. A first indicating portion T1 and a second indicating portion T2 may be respectively formed on the outer peripheral surface of the main body portion 40 where the protrusion insertion groove 45 is formed and the outer peripheral surface of the cover portion 50 where the locking protrusion 54 is formed.

[0084] The first indicator T1 and the second indicator T2 guide the position according to the rotation range of the cover 50 without damaging the capsule 41 located in the capsule receiving portion 42, and selectively discharge only the vaporized pure steam induced by the first guide flow path 12 through the suction contact tube 52, or contain the powder medicine discharged from the capsule 41 in the vaporized steam and discharge it as a powder mixed gas.

[0085] like Figures 1 to 8 As shown, the drug vaporizing inhaler according to the above embodiment first opens the liquid inlet valve 13 of the vaporizing container 10 to fill the first storage space 11 in the vaporizing container 10 with the vaporization promoting composition.

[0086] Afterwards, with the capsule 41 for sealing and storing granular powder medicine placed in the capsule receiving portion 42 of the main body 40 , the main body 40 is threadedly coupled to the upper portion of the vaporizer container 10 , and the cover 50 is coupled to the upper portion of the main body 40 .

[0087] Next, if power is supplied to the particulate vaporization section 30 formed at one end of the vaporization container 10, power is supplied to the heating element 33 through the electrode section 32 in the particulate vaporization section 30. The heating element 33 vaporizes the vaporization-promoting composition induced by the induction section 20 and generates steam. The vaporized steam can pass through the first guide flow path 12 in the vaporization container 10 through the air inlet hole 21a of the fixing plate 21 to which the induction section 20 is fixed, and is discharged through the second guide flow path 43 formed in the main body 40.

[0088] At this time, in the case where a patient with asthma or coronavirus infection only wants to inhale the vaporized steam discharged through the second guide flow path 43, the patient with asthma or coronavirus infection observes the first indicator portion T1 and the second indicator portion T2 formed on the outer peripheral surfaces of the main body 40 and the cover portion 50, so that the rotation of the cover portion 50 is minimized.

[0089] That is, after the locking protrusion 54 formed in the cover portion 50 is placed in the protrusion placement groove 45 formed at one end of the main body portion 40, the rotation of the cover portion 50 is minimized when guided along the guide groove 44 so that it does not pass through the blade moving flow path 42c formed in the capsule receiving portion 42.

[0090] In this way, the capsule 41 placed in the capsule receiving portion 42 will not be cut by the blade 53 formed on the cover portion 50, and the powder medicine will not be discharged from the capsule 41. Therefore, when a patient infected with asthma or coronavirus holds the inhalation contact tube 52 formed on the cover portion 50 and breathes, only the vapor vaporized through the second guide flow path 43 can reach the lungs of the patient infected with asthma or coronavirus.

[0091] On the contrary, when a patient infected with asthma or coronavirus wants to mix the powder medicine in the capsule 41 with the vaporized steam discharged through the second guide flow path 43 and then inhale it, the patient infected with asthma or coronavirus observes the first indicator part T1 and the second indicator part T2 formed on the outer peripheral surfaces of the main body 40 and the cover part 50 to increase the rotation amount of the cover part 50.

[0092] That is, after the locking protrusion 54 formed in the cover portion 50 is placed in the protrusion placement groove 45 at one end formed in the main body portion 40, the rotation amount of the cover portion 50 is increased while being guided to rotate along the guide groove 44 so that it passes through the blade moving flow path 42c formed in the capsule receiving portion 42 and is placed in the protrusion placement groove 45 at the other end.

[0093] In this way, the capsule 41 placed in the capsule receiving portion 42 is cut by the blade 53 formed on the cover portion 50, and the powder medicine sealed and stored in the capsule 41 is discharged. Therefore, when the inhalation contact tube 52 of the cover portion 50 is held and the powder medicine is inhaled, the powder medicine is mixed with the vaporized steam discharged to the mixing space 51 through the second guide flow path 43, and can reach the lungs of patients infected with asthma or coronavirus without loss through the inhalation contact tube 52.

[0094] That is, if a patient infected with asthma or coronavirus inhales the powder medicine discharged from the capsule 41 through the inhalation contact tube 52, the powder medicine can be mixed with the vaporized steam discharged from the mixing space 51 through the second guide flow path 43, thereby, the vaporized steam mixed with the powder medicine can deliver all of the powder medicine to the lungs of the patient infected with asthma or coronavirus.

[0095] Industrial Applicability

[0096] As described above, the technical concept of the medicine vaporizing inhaler of the present invention is described in conjunction with the accompanying drawings, but this is only an exemplary description of the most preferred embodiment of the present invention and the present invention is not limited thereto.

[0097] Therefore, the present invention is not limited to the above-mentioned specific embodiments, and a person skilled in the art may make various modifications and implementations without departing from the spirit of the present invention as claimed in the claims, and such modifications are deemed to fall within the scope of the claims.

Claims

1. A drug vaporizing inhaler, characterized in that: include: A vaporization container having a first storage space for accommodating a vaporization-promoting composition and a first guide flow path for discharging vapor; an induction portion, which is arranged in a state of being inserted from the lower part of the vaporization container into the first storage space, and inducing the vaporization promoting composition contained in the first storage space to be discharged through a capillary phenomenon; a microparticle vaporizing portion that generates heat when electricity is supplied to vaporize the vaporization promoting composition induced by the inducing portion; a body part, which is detachably coupled to the upper part of the vaporizing container, wherein the upper surface of the body part is formed with a capsule receiving part for receiving a capsule, wherein the capsule is sealed and stores powder medicine for patients with asthma or coronavirus infection, and wherein the capsule has a second guide flow path for discharging steam therein, wherein the second guide flow path passes through the upper and lower regions and is in communication with the first guide flow path, and sprays the vaporized steam flowing in from the bottom surface and induced by the vaporizing part toward the capsule located in the capsule receiving part; and a cover part rotatably coupled to the upper surface of the body part to form a mixing space, having an inhalation contact tube for asthma or coronavirus-infected patients communicating with the mixing space and a blade for cutting the capsule accommodated in the capsule accommodation part, wherein the vaporized steam or the powdered medicine discharged from the capsule contained in the vaporized steam guided by the second guide flow path can be inhaled into the lungs of the asthma or coronavirus-infected patient through the inhalation contact tube; The second guide flow path is formed in a twisted tubular shape penetrating vertically, so that when the vaporized steam is sprayed toward the capsule located between the body and the cover, a vortex can be formed in the mixing space provided between the cover and the body.

2. The drug vaporizing inhaler according to claim 1, characterized in that: The capsule receiving portion forms a space for receiving the capsule by a pair of first wall members and a pair of second wall members facing each other, the first wall members supporting the left and right sides of the capsule, and the second wall members being spaced apart in a direction different from the first wall members and supporting both side ends of the capsule. A blade movement flow path through which the blade passes is formed between the first wall surface member and the second wall surface member, so that when the cover portion rotates, the upper surface of the capsule is cut by the blade.

3. The drug vaporizing inhaler according to claim 1, characterized in that: The main body is combined with the upper part of the vaporizing container, a guide groove for guiding the rotation of the cover is formed on the edge side of the upper surface of the main body, and protrusion insertion grooves are formed at both ends of the guide groove.

4. The drug vaporizing inhaler according to claim 3, characterized in that: A pair of blades are formed to protrude from the inner side end of the cover, and a locking protrusion is formed on the inner surface edge side of the cover to be placed in the protrusion insertion groove of the body and rotated along the guide groove.

5. The drug vaporizing inhaler according to claim 4, characterized in that: A first indicator portion and a second indicator portion are respectively formed on the outer circumferential surface of the main body portion where the protrusion insertion groove is formed and the outer circumferential surface of the cover portion where the locking protrusion is formed, for guiding a discharge position where only the steam vaporized through the inhalation contact tube is discharged, or a mixed steam discharge position where the powdered medicine discharged from the capsule can be contained in the vaporized steam and discharged.

6. The drug vaporizing inhaler according to claim 1, characterized in that: The vaporization container further comprises a liquid inlet valve for adding the vaporization promoting composition.

7. The drug vaporizing inhaler according to claim 1, characterized in that: The first guide flow path is partitioned and disposed at the center of the vaporizing container or formed along the inner circumferential surface of the vaporizing container.

8. The drug vaporizing inhaler according to claim 1, characterized in that: The induction part is fixed to a fixing plate formed with an air inflow hole to divide the space inside the vaporization container or the particulate vaporization part into an inner space and an outer space.

9. The drug vaporizing inhaler according to claim 8, characterized in that: The induction part is made of a material selected from the group consisting of multi-layer nickel foam mesh, stainless steel fiber felt, polymer foam, metal porous body, fiber, or a combination thereof.

10. The drug vaporizing inhaler according to claim 8, characterized in that: The particulate vaporization section comprises: an atomizing container, combined with one end of the vaporizing container, and used to accommodate the fixing plate to which the induction part is fixed; An electrode portion for power supply, threadedly coupled to the atomizing container; and The heating element is formed on the outer surface of the induction part housed in the atomizing container, and generates heat according to the power supplied from the electrode part, so that the vaporization promoting composition induced by the induction part is vaporized.

11. The drug vaporizing inhaler according to claim 10, characterized in that: The electrode portion comprises: an electrode body having a suction port communicating with the first guide flow path and a mating threaded portion fixed to the inner bottom surface of the atomizing container in electrical contact, the atomizing container having a hollow structure with both ends open; a negative electrode formed on one side of the electrode body and electrically contacting the heating element; and The positive electrode is formed on one side of the electrode body and is in electrical contact with the heating element.

12. The drug vaporizing inhaler according to claim 11, characterized in that The heating element is suitable for one selected from the following: A heating wire in the form of a filament, connected to the electrode and wound around the induction portion, having a coil structure made of a nickel alloy or a composite material of rare earth elements; A high frequency or ultra-high frequency generating device is connected to the electrode, and the induction part is formed into a flat plate structure closely attached to the high frequency or ultra-high frequency generating device; A method of using a filament-shaped heating wire and a high-frequency or ultra-high-frequency generating device together, wherein the heating wire is connected to the electrode and wound around the induction part, and has a coil structure made of a nickel alloy or a composite material of rare earth elements.

13. The drug vaporizing inhaler according to claim 1, characterized in that: The vaporization promoting composition is one of nutrients, minerals, vitamins, amino acids and physiologically active agents.

14. A drug vaporizing inhaler, characterized in that: include: A vaporization container having a first storage space for accommodating a vaporization-promoting composition and a first guide flow path for discharging vapor; an induction portion, which is arranged in a state of being inserted from the lower part of the vaporization container into the first storage space, and inducing the vaporization promoting composition contained in the first storage space to be discharged through a capillary phenomenon; a microparticle vaporizing portion that generates heat when electricity is supplied to vaporize the vaporization promoting composition induced by the inducing portion; a body part, which is detachably coupled to the upper part of the vaporizing container, wherein the upper surface of the body part is formed with a capsule receiving part for receiving a capsule, wherein the capsule is sealed and stores powder medicine for patients with asthma or coronavirus infection, and wherein the capsule has a second guide flow path for discharging steam therein, wherein the second guide flow path passes through the upper and lower regions and is in communication with the first guide flow path, and sprays the vaporized steam flowing in from the bottom surface and induced by the vaporizing part toward the capsule located in the capsule receiving part; and a cover part rotatably coupled to the upper surface of the body part to form a mixing space, having an inhalation contact tube for asthma or coronavirus-infected patients communicating with the mixing space and a blade for cutting the capsule accommodated in the capsule accommodation part, wherein the vaporized steam or the powdered medicine discharged from the capsule contained in the vaporized steam guided by the second guide flow path can be inhaled into the lungs of the asthma or coronavirus-infected patient through the inhalation contact tube; The capsule receiving portion forms a space for receiving the capsule by a pair of first wall members and a pair of second wall members facing each other, the first wall members supporting the left and right sides of the capsule, and the second wall members being spaced apart in a direction different from the first wall members and supporting both side ends of the capsule. A blade moving flow path through which the blade passes is formed between the first wall member and the second wall member, so that when the cover rotates, the upper side of the capsule is cut by the blade; The second guide flow path forms an "L"-shaped channel connected from the bottom surface of the main body to the inner wall surface of the capsule receiving portion, and the inner outlet of the channel is adjacent to the blade moving flow path separated by the space between the plate-shaped first wall component and the arc-shaped second wall component arranged in the capsule receiving portion.

15. The drug vaporizing inhaler according to claim 14, characterized in that The main body is combined with the upper part of the vaporizing container, a guide groove for guiding the rotation of the cover is formed on the edge side of the upper surface of the main body, and protrusion insertion grooves are formed at both ends of the guide groove.

16. The drug vaporizing inhaler according to claim 15, characterized in that A pair of blades are formed to protrude from the inner side end of the cover, and a locking protrusion is formed on the inner surface edge side of the cover to be placed in the protrusion insertion groove of the body and rotated along the guide groove.

17. The drug vaporizing inhaler according to claim 16, characterized in that A first indicator portion and a second indicator portion are respectively formed on the outer circumferential surface of the main body portion where the protrusion insertion groove is formed and the outer circumferential surface of the cover portion where the locking protrusion is formed, for guiding a discharge position where only the steam vaporized through the inhalation contact tube is discharged, or a mixed steam discharge position where the powdered medicine discharged from the capsule can be contained in the vaporized steam and discharged.

18. The drug vaporizing inhaler according to claim 14, characterized in that: The vaporization container further comprises a liquid inlet valve for adding the vaporization promoting composition.

19. The drug vaporizing inhaler according to claim 14, characterized in that: The first guide flow path is partitioned and disposed at the center of the vaporizing container or formed along the inner circumferential surface of the vaporizing container.

20. The drug vaporizer inhaler according to claim 14, characterized in that The induction part is fixed to a fixing plate formed with an air inflow hole to divide the space inside the vaporization container or the particulate vaporization part into an inner space and an outer space.

21. The drug vaporizing inhaler according to claim 20, characterized in that The induction part is made of a material selected from the group consisting of multi-layer nickel foam mesh, stainless steel fiber felt, polymer foam, metal porous body, fiber, or a combination thereof.

22. The drug vaporizing inhaler according to claim 20, characterized in that The particulate vaporization section comprises: an atomizing container, combined with one end of the vaporizing container, and used to accommodate the fixing plate to which the induction part is fixed; An electrode portion for power supply, threadedly coupled to the atomizing container; and The heating element is formed on the outer surface of the induction part housed in the atomizing container, and generates heat according to the power supplied from the electrode part, so that the vaporization promoting composition induced by the induction part is vaporized.

23. The drug vaporizing inhaler according to claim 22, characterized in that The electrode portion comprises: an electrode body having a suction port communicating with the first guide flow path and a mating threaded portion fixed to the inner bottom surface of the atomizing container in electrical contact, the atomizing container having a hollow structure with both ends open; a negative electrode formed on one side of the electrode body and electrically contacting the heating element; and The positive electrode is formed on one side of the electrode body and is in electrical contact with the heating element.

24. The drug vaporizing inhaler according to claim 23, characterized in that The heating element is suitable for one selected from the following: A heating wire in the form of a filament, connected to the electrode and wound around the induction portion, having a coil structure made of a nickel alloy or a composite material of rare earth elements; A high frequency or ultra-high frequency generating device is connected to the electrode, and the induction part is formed into a flat plate structure closely attached to the high frequency or ultra-high frequency generating device; A method of using a filament-shaped heating wire and a high-frequency or ultra-high-frequency generating device together, wherein the heating wire is connected to the electrode and wound around the induction part, and has a coil structure made of a nickel alloy or a composite material of rare earth elements.

25. The drug vaporizing inhaler according to claim 14, characterized in that The vaporization promoting composition is one of nutrients, minerals, vitamins, amino acids and physiologically active agents.

26. A drug vaporizing inhaler, characterized in that: include: A vaporization container having a first storage space for accommodating a vaporization-promoting composition and a first guide flow path for discharging vapor; an induction portion, which is arranged in a state of being inserted from the lower part of the vaporization container into the first storage space, and inducing the vaporization promoting composition contained in the first storage space to be discharged through a capillary phenomenon; a microparticle vaporizing portion that generates heat when electricity is supplied to vaporize the vaporization promoting composition induced by the inducing portion; a body part, which is detachably coupled to the upper part of the vaporizing container, wherein the upper surface of the body part is formed with a capsule receiving part for receiving a capsule, wherein the capsule is sealed and stores powder medicine for patients with asthma or coronavirus infection, and wherein the capsule has a second guide flow path for discharging steam therein, wherein the second guide flow path passes through the upper and lower regions and is in communication with the first guide flow path, and sprays the vaporized steam flowing in from the bottom surface and induced by the vaporizing part toward the capsule located in the capsule receiving part; and a cover part rotatably coupled to the upper surface of the body part to form a mixing space, having an inhalation contact tube for asthma or coronavirus-infected patients communicating with the mixing space and a blade for cutting the capsule accommodated in the capsule accommodation part, wherein the vaporized steam or the powdered medicine discharged from the capsule contained in the vaporized steam guided by the second guide flow path can be inhaled into the lungs of the asthma or coronavirus-infected patient through the inhalation contact tube; The second guide flow path has a vertical flow path and a horizontal flow path, which as a whole form a connecting channel with an "L"-shaped end face. The vertical flow path is formed along the vertical direction from the bottom surface of the main body, and the horizontal flow path is laterally connected to the vertical flow path and the outlet is open to the inner wall surface of the capsule receiving portion.

27. The drug vaporizing inhaler according to claim 26, characterized in that The capsule receiving portion forms a space for receiving the capsule by a pair of first wall members and a pair of second wall members facing each other, the first wall members supporting the left and right sides of the capsule, and the second wall members being spaced apart in a direction different from the first wall members and supporting both side ends of the capsule. A blade movement flow path through which the blade passes is formed between the first wall surface member and the second wall surface member, so that when the cover portion rotates, the upper surface of the capsule is cut by the blade.

28. The drug vaporizing inhaler according to claim 26, characterized in that The main body is combined with the upper part of the vaporizing container, a guide groove for guiding the rotation of the cover is formed on the edge side of the upper surface of the main body, and protrusion insertion grooves are formed at both ends of the guide groove.

29. The drug vaporizing inhaler according to claim 28, characterized in that A pair of blades are formed to protrude from the inner side end of the cover, and a locking protrusion is formed on the inner surface edge side of the cover to be placed in the protrusion insertion groove of the body and rotated along the guide groove.

30. The drug vaporizing inhaler according to claim 29, characterized in that A first indicator portion and a second indicator portion are respectively formed on the outer circumferential surface of the main body portion where the protrusion insertion groove is formed and the outer circumferential surface of the cover portion where the locking protrusion is formed, for guiding a discharge position where only the steam vaporized through the inhalation contact tube is discharged, or a mixed steam discharge position where the powdered medicine discharged from the capsule can be contained in the vaporized steam and discharged.

31. The drug vaporizer inhaler according to claim 26, characterized in that The horizontal flow path opened to the inner wall surface of the capsule receiving portion maintains an inclination of 15 to 45 degrees from the center of the main body to one side, so that the vaporized steam passing through the first guide flow path and ejected through the second guide flow path for discharging steam is directed toward the cut surface of the capsule cut on the upper side with the help of a blade for cutting a portion of the capsule surface, and at the same time can form a vortex in the mixing space.

32. The drug vaporizer inhaler according to claim 26, characterized in that The vaporization container further comprises a liquid inlet valve for adding the vaporization promoting composition.

33. The drug vaporizing inhaler according to claim 26, characterized in that The first guide flow path is partitioned and disposed at the center of the vaporizing container or formed along the inner circumferential surface of the vaporizing container.

34. The drug vaporizer inhaler according to claim 26, characterized in that The induction part is fixed to a fixing plate formed with an air inflow hole to divide the space inside the vaporization container or the particulate vaporization part into an inner space and an outer space.

35. The drug vaporizing inhaler according to claim 34, characterized in that The induction part is made of a material selected from the group consisting of multi-layer nickel foam mesh, stainless steel fiber felt, polymer foam, metal porous body, fiber, or a combination thereof.

36. The drug vaporizing inhaler according to claim 34, characterized in that The particulate vaporization section comprises: an atomizing container, combined with one end of the vaporizing container, and used to accommodate the fixing plate to which the induction part is fixed; An electrode portion for power supply, threadedly coupled to the atomizing container; and The heating element is formed on the outer surface of the induction part housed in the atomizing container, and generates heat according to the power supplied from the electrode part, so that the vaporization promoting composition induced by the induction part is vaporized.

37. The drug vaporizing inhaler according to claim 36, characterized in that The electrode portion comprises: an electrode body having a suction port communicating with the first guide flow path and a mating threaded portion fixed to the inner bottom surface of the atomizing container in electrical contact, the atomizing container having a hollow structure with both ends open; a negative electrode formed on one side of the electrode body and electrically contacting the heating element; and The positive electrode is formed on one side of the electrode body and is in electrical contact with the heating element.

38. The drug vaporizing inhaler according to claim 37, characterized in that The heating element is suitable for one selected from the following: A heating wire in the form of a filament, connected to the electrode and wound around the induction portion, having a coil structure made of a nickel alloy or a composite material of rare earth elements; A high frequency or ultra-high frequency generating device is connected to the electrode, and the induction part is formed into a flat plate structure closely attached to the high frequency or ultra-high frequency generating device; A method of using a filament-shaped heating wire and a high-frequency or ultra-high-frequency generating device together, wherein the heating wire is connected to the electrode and wound around the induction part, and has a coil structure made of a nickel alloy or a composite material of rare earth elements.

39. The drug vaporizer inhaler according to claim 26, characterized in that The vaporization promoting composition is one of nutrients, minerals, vitamins, amino acids and physiologically active agents.

Images